- Language: English
- 499 Pages
- Published: December 2010
- Region: Asia
Asia-Pacific Markets for Cardiac Rhythm Management, Electrophysiology & Ablation Devices 2011 (Executive Summary)
- Published: November 2010
- Region: Asia
- 8 Pages
- iData Research
In 2010, the Asia Pacific markets for cardiac rhythm management (CRM), electrophysiology and ablation devices were valued at over $1.4 billion. This market covers:
- Implantable Cardioverter-Defibrillators (ICDs),
- Cardiac Resynchronization Therapy devices (CRTs),
- Cardiac stimulation leads,
- External defibrillators,
- Ablation catheters, and
- Diagnostic electrophysiology (EP) catheters
The countries covered in this report include Japan, South Korea and Australia.
Although the markets declined slightly in 2010, they are expected to reach $2 billion by 2017.
Within the cardiac rhythm management (CRM), electrophysiology and ablation device report, companies such as Boston Scientific, Cardiac Science, Medtronic, Sorin Group and St. Jude Medical lead the market, among many others. This report provides a comprehensive and detailed analysis of market revenues by device type, market forecasts through 2016, unit sales, average selling prices, market drivers and limiters and a detailed competitive analysis, including manufacturer market shares and product portfolios.
This is an executive summary only, the full-report is also available for purchase.
1.1 TOTAL ASIA PACIFIC CARDIAC RHYTHM MANAGEMENT, ELECTROPHYSIOLOGY AND ABLATION DEVICE MARKETS
1.2 PACEMAKER MARKET
1.3 IMPLANTABLE CARDIOVERTER DEFIBRILLATOR MARKET
1.4 CARDIAC RESYNCHRONIZATION THERAPY DEVICE MARKET
1.5 CARDIAC LEAD MARKET
1.6 EXTERNAL DEFIBRILLATOR MARKET
1.7 CARDIAC ABLATION MARKET
1.8 DIAGNOSTIC ELECTROPHYSIOLOGY MARKET
1.9 COMPETITIVE ANALYSIS